Inhibiting phosphatase SHIP-1 enhances suboptimal IgE-mediated activation of human blood basophils but inhibits IgE-mediated activation of cultured human mast cells.


Journal

Immunology letters
ISSN: 1879-0542
Titre abrégé: Immunol Lett
Pays: Netherlands
ID NLM: 7910006

Informations de publication

Date de publication:
06 2019
Historique:
received: 12 11 2018
revised: 10 04 2019
accepted: 16 04 2019
pubmed: 21 4 2019
medline: 23 2 2020
entrez: 21 4 2019
Statut: ppublish

Résumé

IgE-mediated activation of basophil granulocytes and mast cells follows a bell-shaped dose-response curve. The decreased activation at supraoptimal allergen stimulation is thought to be associated with SH2-containing inositol-5'-phosphatase 1 (SHIP-1). SHIP-1 phosphorylation is inversely related to IgE-mediated releasability of basophils. This study sought to clarify the regulatory role of SHIP-1 in degranulation of basophil granulocytes and mast cells by selective inhibition of the phosphatase function of SHIP-1with 3-α-aminocholestane (3-α-AC). Six grass pollen allergic patients, six non-responder patients and six cultured human primary mast cell lines were included. The effect of 3-α-AC (1-60 μM, 30 min, 37 °C) was analyzed at individual suboptimal, optimal and supra-optimal allergen concentrations. The activity, upregulation of CD63, measured at different conditions was compared to evaluate the maximal effect of selective SHIP-1 inhibition. Basophils of five non-responder patients were treated with 3-α-AC (10 μM, 30 min, 37 °C). At high concentrations (>60 μM) of 3-α-AC, cells appeared to enter apoptosis. The median reactivity increased from 27.1% to 44.9% CD63

Identifiants

pubmed: 31004680
pii: S0165-2478(18)30509-1
doi: 10.1016/j.imlet.2019.04.003
pii:
doi:

Substances chimiques

Allergens 0
Receptors, IgE 0
Immunoglobulin E 37341-29-0
INPP5D protein, human EC 3.1.3.86
Phosphatidylinositol-3,4,5-Trisphosphate 5-Phosphatases EC 3.1.3.86

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

40-46

Informations de copyright

Copyright © 2019 European Federation of Immunological Societies. Published by Elsevier B.V. All rights reserved.

Auteurs

Pernille Rasmussen (P)

Department of Respiratory Diseases and Allergy, Aarhus University Hospital, Denmark.

Edzard Spillner (E)

Department of Engineering, Aarhus University, Denmark.

Hans Jürgen Hoffmann (HJ)

Department of Clinical Medicine, Aarhus University, Denmark. Electronic address: hjh@clin.au.dk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH